Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome

Azacitidine is a first-in-class demethylating agent, and it is widely used globally as a first-line treatment for higher-risk myelodysplastic syndrome (MDS). Here, we report the case of a patient with MDS who suffered from a rare adverse event, an acute lung injury (ALI), which was suspected to have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int Med Res
Main Authors: Makita, Shinichi, Munakata, Wataru, Watabe, Daisuke, Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Toyoda, Kosuke, Yamauchi, Nobuhiko, Fukuhara, Suguru, Maruyama, Dai, Kobayashi, Yukio, Tobinai, Kensei
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536648/
https://ncbi.nlm.nih.gov/pubmed/28415946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060517698331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados